Popular GLP-1 drugs help people drop many pounds, but the drugs fail to provide a key improvement in heart and lung function, UVA finds.| UVA Health Newsroom
Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year.| UVA Health Newsroom
Continuous glucose monitors can predict complications from type 1 diabetes, UVA Center for Diabetes Technology researchers have found.| UVA Health Newsroom